Sustained community transmission from multiple large outbreaks, fueled by declining MMR vaccination coverage in key communities, drives elevated trader expectations for a record 2026 U.S. measles total. As of September 10, CDC data show 3,294 confirmed cases—already exceeding the full-year 2025 count of 2,289—with 95% outbreak-associated, 94% among unvaccinated or unknown-status individuals, and 8% hospitalized across 47 jurisdictions. Pennsylvania now leads with rapid growth, followed by South Carolina and Utah, while official counts remain preliminary and subject to revision. Weekly CDC surveillance updates, wastewater monitoring, and the November Pan American Health Organization review of elimination status represent key near-term data points that could shift market-implied odds as new case reports and vaccination trends emerge.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoPrzypadki odry w USA w 2026 roku?
Przypadki odry w USA w 2026 roku?
$7,898,062 Wol.
$7,898,062 Wol.
Dec 31, 2026
↑3.5k
99%
↑4k
97%
↑4.5k
86%
↑4.75k
86%
↑5k
70%
↑7,5 tys.
15%
↑10k
7%
↑12,5 tys.
2%
$7,898,062 Wol.
$7,898,062 Wol.
Dec 31, 2026
↑3.5k
$15,573 Wol.
99%
↑4k
$241,109 Wol.
97%
↑4.5k
$2,930 Wol.
86%
↑4.75k
$626 Wol.
86%
↑5k
$242,023 Wol.
70%
↑7,5 tys.
$194,220 Wol.
15%
↑10k
$6,524,884 Wol.
7%
↑12,5 tys.
$356,740 Wol.
2%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained community transmission from multiple large outbreaks, fueled by declining MMR vaccination coverage in key communities, drives elevated trader expectations for a record 2026 U.S. measles total. As of September 10, CDC data show 3,294 confirmed cases—already exceeding the full-year 2025 count of 2,289—with 95% outbreak-associated, 94% among unvaccinated or unknown-status individuals, and 8% hospitalized across 47 jurisdictions. Pennsylvania now leads with rapid growth, followed by South Carolina and Utah, while official counts remain preliminary and subject to revision. Weekly CDC surveillance updates, wastewater monitoring, and the November Pan American Health Organization review of elimination status represent key near-term data points that could shift market-implied odds as new case reports and vaccination trends emerge.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Rynek otwarty: Jun 30, 2026, 2:17 PM ET
Wolumen
$7,898,062Data zakończenia
Jan 1, 2027Rynek otwarty
Jun 30, 2026, 2:17 PM ETRozstrzygający
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained community transmission from multiple large outbreaks, fueled by declining MMR vaccination coverage in key communities, drives elevated trader expectations for a record 2026 U.S. measles total. As of September 10, CDC data show 3,294 confirmed cases—already exceeding the full-year 2025 count of 2,289—with 95% outbreak-associated, 94% among unvaccinated or unknown-status individuals, and 8% hospitalized across 47 jurisdictions. Pennsylvania now leads with rapid growth, followed by South Carolina and Utah, while official counts remain preliminary and subject to revision. Weekly CDC surveillance updates, wastewater monitoring, and the November Pan American Health Organization review of elimination status represent key near-term data points that could shift market-implied odds as new case reports and vaccination trends emerge.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Wolumen
$7,898,062Data zakończenia
Jan 1, 2027Rynek otwarty
Jun 30, 2026, 2:17 PM ETRozstrzygający
0x65070BE91...Sustained community transmission from multiple large outbreaks, fueled by declining MMR vaccination coverage in key communities, drives elevated trader expectations for a record 2026 U.S. measles total. As of September 10, CDC data show 3,294 confirmed cases—already exceeding the full-year 2025 count of 2,289—with 95% outbreak-associated, 94% among unvaccinated or unknown-status individuals, and 8% hospitalized across 47 jurisdictions. Pennsylvania now leads with rapid growth, followed by South Carolina and Utah, while official counts remain preliminary and subject to revision. Weekly CDC surveillance updates, wastewater monitoring, and the November Pan American Health Organization review of elimination status represent key near-term data points that could shift market-implied odds as new case reports and vaccination trends emerge.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania